Inhibitors of Interleukin-1 converting enzyme

The present invention relates to novel classes of compounds which are inhibitors of interleukin - l converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BEBBINGTON, DAVID, FRIDMAN, WOLF HERMAN, ANDREA L.C. ROBIDOUX, GILLESPIE, ROGER JOHN, JULIAN M.C. GOLEC, YONG GU, ROBERT MURDOCH, SU, MICHAEL, PHILIP L. NYCE, DAVID J. LAUFFER, BATCHELOR, MARK JAMES, BEMIS, GUY W
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to novel classes of compounds which are inhibitors of interleukin - l converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against IL-1-, apoptosis-, IGIF-, and IFN- -mediated diseases, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases. This invention also relates to pharmaceutical compositions formulated for use in inhibiting ICE activity, for treating interleukin-1-, apoptosis-, IGIF- and IFN- -mediated diseases and decreasing IGIF and IFN- production using the compounds and compositions of this invention. This invention also relates to